Aug 2026· Journal of Agricultural and Food Chemistry· Vol 74 31, pp.
24513-24522
· 0 citations· 52 references
Medicine
Abstract
(R)-citronellal is an important intermediate for aroma compounds and pharmaceuticals. Herein, we engineered the choline oxidase, AcCO6, from Arthrobacter chlorophenolicus, to enhance enantioselective oxidation of citronellol. Through site-directed and combinatorial mutagenesis, a quadruple mutant, AcCO6_M4a (W332V/A89S/W331F/N463E) was obtained, exhibiting 336% of the wild-type activity and a 10.2-fold improvement in enantioselectivity (E = 24.2). Structural analysis and MD simulations revealed that the mutations expanded the binding pocket, promoting favorable interactions with (R)-citronellol and enhancing hydride transfer, while disfavoring the (S)-enantiomer. Consequently, the catalytic efficiency (kcat/KM) for (R)-citronellol was 12.5-fold higher than that for (S)-citronellol. Kinetic resolution of racemic citronellol using AcCO6_M4a achieved approximately 50% conversion, yielding (R)-citronellal (86.7% ee) and (S)-citronellol (97.9% ee) with 39.1% and 42.0% yield, respectively. This work demonstrates the potential of engineered AcCO6 for enantioselective biocatalysis, offering an efficient route to synthesize chiral alcohols and aldehydes as intermediates for fragrances and pharmaceuticals.
In this study, a previously uncharacterized neral reductase (an ene-reductase), SmNR (Serratia marcescens Neral Reductase), belonging to the Old Yellow Enzyme family, was identified and functionally characterized from Serratia marcescens HBQA7. SmNR efficiently catalyzes the asymmetric reduction of neral to produce (S)...
Rui-Shi Xie, Long Wang, Sheng-Fang Wu et al.· International Journal of Bio...· 0 citations
This study establishes a robust chassis for sustainable DPA production and provides a generalizable framework for engineering other valuable biochemicals.
Qing Yang, Tao-Shun Zhou, Bo Zhang et al.· Biotechnology and Bioenginee...· 0 citations
(R)-Selective ω-transaminases are valuable biocatalysts for the synthesis of chiral amines and pharmaceutical intermediates, but their practical application is often limited by insufficient catalytic efficiency, poor operational stability and unfavorable reaction equilibrium. Here, an Actinomycete-derived (R)-selective...
Xin-Yu Lu, Feng Guo, Cao-Kai Zhu et al.· International Journal of Bio...· 0 citations
The biocatalytic asymmetric amination of bulky N-heterocyclic ketones is often limited by low enzyme activity and poor performance at high substrate loading. Herein, we developed an efficient (R)-selective transaminase for the synthesis of (R)-1-Boc-3-aminopiperidine through an integrated strategy combining phylogeny-g...
Zhe Dou, Hui-Xuan Yan, Cheng Xu et al.· Biotechnology and Bioenginee...· 0 citations
R reverse screening as an effective approach for evolving transaminases toward sterically hindered substrates is validates reverse screening as an effective approach for evolving transaminases toward sterically hindered substrates and highlights RTA-223 as a promising candidate for further biocatalyst development.
Matthew Treadell, Gareth R E Surman, G. Ford et al.· RSC Chemical Biology· 0 citations
The present study provides efficient access to valuable drug-like enantiopure alcohols suitable for inclusion in chiral fragment-based drug discovery (FBDD) libraries using microbial whole-cell ketoreductases.
Máté Gergő Honvári, Levente András Mócza, Máté Laurinyecz et al.· Applied Microbiology and Bio...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.